Datametrex AI Limited (CVE:DM - Get Free Report) was up 14.3% on Monday . The company traded as high as C$0.12 and last traded at C$0.12. Approximately 102,978 shares were traded during trading, an increase of 149% from the average daily volume of 41,393 shares. The stock had previously closed at C$0.11.
Datametrex AI Price Performance
The company has a quick ratio of 2.44, a current ratio of 0.40 and a debt-to-equity ratio of 554.49. The company has a market cap of C$66.44 million, a P/E ratio of -1.57 and a beta of 2.59. The business's 50 day moving average is C$0.08 and its 200 day moving average is C$0.04.
Datametrex AI Company Profile
(
Get Free Report)
Datametrex AI Limited engages in the collecting, analyzing, and presenting structured and unstructured data using machine learning and artificial intelligence in Canada and South Korea. The company operates through two segments, AI and Technology and Health Care. It offers health security businesses, including concierge medical services, and telemedicine services; Imagine Health consisting of integrated medical centre, pharmacy, and ancillary services; physician consultation and medical professional services; and sale of prescription drugs and over-the-counter products.
See Also
Before you consider Datametrex AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Datametrex AI wasn't on the list.
While Datametrex AI currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.